Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.
Sjoerd Rodenhuis(The Netherlands Cancer Institute), Johannes L. Bos(University Medical Center Utrecht), S S Wagenaar, Robbert J.C. Slebos, Peter C. Van Bodegom, W. J. Mooi, A J Boot, Siegina G. Evers
PubMed
October 15, 1988
Cited by 464
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
K-<i>ras</i>Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
|New England Journal of Medicine|1990|811
Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy
|JNCI Journal of the National Cancer Institute|1998|768
Mutational Activation of the K-<i>ras</i>Oncogene
|New England Journal of Medicine|1987|540